GSK wins $3.0-bln takeover of Human Genome Sciences
British drugmaker GlaxoSmithKline on Monday clinched the takeover of US research partner Human Genome Sciences Inc. after increasing its bid to $3.0 billion (2.4 billion euros).
Good Health is Your Greatest Wealth……Virgil